These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 8438050

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. AZT-induced mitochondrial myopathy.
    Tomelleri G, Tonin P, Spadaro M, Tilia G, Orrico D, Barelli A, Bonetti B, Monaco S, Salviati A, Morocutti C.
    Ital J Neurol Sci; 1992 Dec; 13(9):723-8. PubMed ID: 1336487
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Zidovudine-induced experimental myopathy: dual mechanism of mitochondrial damage.
    Masini A, Scotti C, Calligaro A, Cazzalini O, Stivala LA, Bianchi L, Giovannini F, Ceccarelli D, Muscatello U, Tomasi A, Vannini V.
    J Neurol Sci; 1999 Jul 01; 166(2):131-40. PubMed ID: 10475107
    [Abstract] [Full Text] [Related]

  • 25. Nuclear and mitochondrial changes of muscle fibers in AIDS after treatment with high doses of zidovudine.
    Schröder JM, Bertram M, Schnabel R, Pfaff U.
    Acta Neuropathol; 1992 Jul 01; 85(1):39-47. PubMed ID: 1285495
    [Abstract] [Full Text] [Related]

  • 26. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1993 Sep 01; 422():1-340. PubMed ID: 12616289
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Necrotising myopathy, an unusual presentation of a steroid-responsive myopathy.
    Bronner IM, Hoogendijk JE, Wintzen AR, van der Meulen MF, Linssen WH, Wokke JH, de Visser M.
    J Neurol; 2003 Apr 01; 250(4):480-5. PubMed ID: 12700915
    [Abstract] [Full Text] [Related]

  • 35. Cytochrome c oxidase deficiency in zidovudine myopathy affects perifascicular muscle fibres and arterial smooth muscle cells.
    Chariot P, Le Maguet F, Authier FJ, Labes D, Poron F, Gherardi R.
    Neuropathol Appl Neurobiol; 1995 Dec 01; 21(6):540-7. PubMed ID: 8745244
    [Abstract] [Full Text] [Related]

  • 36. AIDS Clinical Trials Group Study 094: a phase I/II trial of ABV chemotherapy with zidovudine and recombinant human GM-CSF in AIDS-related Kaposi's sarcoma.
    Gill PS, Mitsuyasu RT, Montgomery T, Huang J, Cabriales S, Testa M, Espina BM, Levine AM, Miles SA.
    Cancer J Sci Am; 1997 Dec 01; 3(5):278-83. PubMed ID: 9327151
    [Abstract] [Full Text] [Related]

  • 37. [Muscular involvement in the course of AIDS. Anatomo-clinical study of 17 cases].
    Butori C, Desnuelle C, Hofman P, Paquis V, Durant J, Carles M, Pesce A, Michiels JF.
    Ann Pathol; 1995 Dec 01; 15(6):424-30. PubMed ID: 8720838
    [Abstract] [Full Text] [Related]

  • 38. Myopathy in human immunodeficiency virus-infected children receiving long-term zidovudine therapy.
    Walter EB, Drucker RP, McKinney RE, Wilfert CM.
    J Pediatr; 1991 Jul 01; 119(1 Pt 1):152-5. PubMed ID: 1906098
    [No Abstract] [Full Text] [Related]

  • 39. Exacerbation of HIV-associated myopathy by zidovudine.
    Berger JR, Shebert R, Gregorios JB.
    AIDS; 1991 Feb 01; 5(2):229-30. PubMed ID: 2031699
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.